Do you want to read an article? Please log in or register.
Proactive Management and Treatment of Aortic Stenosis: An International Expert Perspective
Heart, Artery and Coronary Diseases
Related content
Heart, Artery and Coronary Diseases
The Effects of Low-Dose Colchicine on the Progression of Aortic Valve Stenosis: Rationale, Design, and Baseline Characteristics of the Colchicine and Inflammation in Aortic Stenosis (CHIANTI) trial
Am Heart J
Mohammadnia N, Vestjens LTW, Craig NJ, Tijssen JGP, Knol RJJ, Lazarenko SV, Duffels MGJ, Focks JJ, Hemels MEW, Oving I, Schalkx HJ, Eikelboom JW, Cetinyurek-Yavuz A, Aarntzen EHJG, Dey D, Slomka PJ, Nijveldt R, Riksen NP, van Royen N, Honigberg MC, Dweck MR, Cornel JH, Messaoudi SE
doi: 10.1016/j.ahj.2025.07.010
Further Publications
Cardiac transthyretin amyloidosis treatment improves outcomes after aortic valve replacement for severe stenosis
Eur Heart J
Nitsche C, Dobner S, Rosenblum HR, Patel KP, Longhi S, Yilmaz A, Merlo M, Papathanasiou M, Griffin J, Oerlemans MIFJ, Gama F, Hamdan A, Kelion AD, Schuster A, Glaveckaité S, Akyol N, Porcari A, Schlender L, Capovilla T, Autherith M, Hauptmann L, Halavina K, Cavalcante JL, Fontana M, Scully PR, Moon JC, Mascherbauer J, Ristl R, Biagini E, Stortecky S, Maurer MS, Treibel TA, AS-Amyloidosis Consortium
doi: 10.1093/eurheartj/ehaf362
Heart, Artery and Coronary DiseasesTherapy and Intervention
Sex-specific outcomes after transcatheter or surgical treatment of aortic valve stenosis: the DEDICATE-DZHK6 trial
Eur Heart J
Bleiziffer S, Leuschner F, Rudolph TK, Vonthein R, Meyer AL, Haeusler KG, Hofmann U, Gorski A, Hagendorff A, Kim WK, Baumgartner H, Borger MA, Choi YH, Cremer J, Falk V, Frey N, Hagl C, König IR, Landmesser U, Massberg S, Reichenspurner H, Renker M, Thiele H, Walther T, Ziegler A, Blankenberg S, Dreger H, Arif R, Unbehaun A, Seiffert M, DEDICATE Study Investigators
doi: 10.1093/eurheartj/ehaf519
Heart, Artery and Coronary DiseasesTherapy and Intervention
Transcatheter or Surgical Treatment of Patients With Aortic Stenosis at Low to Intermediate Risk: An Individual Participant Data Meta-Analysis
JAMA Cardiol
Ludwig S, Klimek M, Bay B, Blankenberg S, Granada JF, Hildick-Smith D, Hudson J, Jørgensen TH, Leon MB, Magnussen C, Thiele H, Hørsted Thyregod HG, Wendler O, de Backer O, Toff WD, Ziegler A, Seiffert M
doi: 10.1001/jamacardio.2025.3403
Heart Failure
Management of aortic stenosis and chronic heart failure: A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC
Eur J Heart Fail
Adamo M, Pagnesi M, Chioncel O, Bayes-Genis A, Abdelhamid M, Antohi EL, Bucciarelli-Ducci C, Chieffo A, Cosyns B, Gilard M, Grapsa J, González A, Gustafsson F, Iung B, Joner M, Karam N, Lund LH, Maisano F, Moura B, Praz F, Rudolph TK, Sannino A, Savarese G, Tocchetti CG, Van Empel VPM, Volterrani M, Windecker S, Ponikowski P, Rosano GMC, Barbato E, Metra M
doi: 10.1002/ejhf.70023
Heart, Artery and Coronary DiseasesTherapy and Intervention
5-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis
J Am Coll Cardiol
Forrest JK, Yakubov SJ, Deeb GM, Gada H, Mumtaz MA, Ramlawi B, Bajwa T, Crouch J, Merhi W, Wai Sang SL, Kleiman NS, Petrossian G, Robinson NB, Sorajja P, Iskander A, Berthoumieu P, Tchétché D, Feindel C, Horlick EM, Saito S, Oh JK, Jung Y, Reardon MJ, Low Risk Trial Investigators
doi: 10.1016/j.jacc.2025.03.004
Heart, Artery and Coronary Diseases
High residual gradients after transcatheter aortic valve implantation in raphe-type bicuspid aortic valve stenosis: insights from the AD-HOC registry
Clin Res Cardiol
Tartaglia F, Gitto M, Kim WK, Leone PP, Fabris T, De Biase C, Costa G, Montarello N, Scotti A, Bellamoli M, Alfadhel M, Koren O, Fezzi S, Bellini B, Massussi M, Costa G, Fraccaro C, Mazzapicchi A, Giacomin E, Burzotta F, Zito A, Gorla R, Angelillis M, Hug K, Briguori C, Bettari L, Messina A, Galasso M, Regazzoli D, Cattaneo G, Boiago M, Calamita G, Laterra G, Renker M, Garcia Gomez M, Ielasi A, Landes U, Rheude T, Bedogni F, Amat Santos I, Saia F, Bai L, Chen M, Adamo M, De Carlo M, Montorfano M, Makkar RR, Mylotte D, Blackman DJ, Barbanti M, Tchetche D, Tarantini G, Latib A, Maffeo D, De Backer O, Buono A, Mangieri A
doi: 10.1007/s00392-025-02726-0
RECOMMENDED
Hypertension
Targets for Treatment and Optimal Strategies for Non-Pharmacological and Pharmacological Management of Hypertension
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
Eur J Prev Cardiol
van den Born BH, Bejan-Angoulvant T, Pengo MF, Mahfoud F, Sudano I, Hanssen H, Parati G
doi: 10.1093/eurjpc/zwaf610
Heart, Artery and Coronary DiseasesTherapy and Intervention
ACURATE neo2 valve versus commercially available transcatheter heart valves in patients with severe aortic stenosis (ACURATE IDE): a multicentre, randomised, controlled, non-inferiority trial
Lancet
Makkar RR, Ramana RK, Gnall E, Ramlawi B, Cheng W, Diamantouros P, Potluri S, Kleinman N, Gupta A, Chakravarty T, Samy S, Rassi A, Rajagopal V, Yakubov S, Sorajja P, Patel D, Garcia S, Yadav P, Thourani V, Wang J, Rinaldi M, Kapadia S, Waksman R, Webb J, Ren CB, Gregson J, Modolo R, Sathananthan J, Reardon MJ, ACURATE IDE study investigators
doi: 10.1016/S0140-6736(25)00319-8